Wallia Amisha, Umpierrez Guillermo E, Nasraway Stanley A, Klonoff David C
Northwestern University, Feinberg School of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Chicago, IL, USA
Emory University School of Medicine, Atlanta, GA, USA.
J Diabetes Sci Technol. 2016 Aug 22;10(5):1174-81. doi: 10.1177/1932296816656380. Print 2016 Sep.
In May 2015 the Diabetes Technology Society convened a panel of 27 experts in hospital medicine and endocrinology to discuss the current and potential future roles of continuous glucose monitoring (CGM) in delivering optimum health care to hospitalized patients in the United States. The panel focused on 3 potential settings for CGM in the hospital, including (1) the intensive care unit (ICU), (2) non-ICU, and (3) continuation of use of home CGM in the hospital. The group reviewed barriers to use and solutions to overcome the barriers. They concluded that CGM has the potential to improve the quality of patient care and can provide useful information to help health care providers learn more about glucose management. Widespread adoption of CGM by hospitals, however, has been limited by added costs and insufficient outcome data.
2015年5月,糖尿病技术协会召集了一个由27名医院医学和内分泌学专家组成的小组,讨论连续血糖监测(CGM)在美国为住院患者提供最佳医疗保健方面当前和未来可能发挥的作用。该小组重点关注了CGM在医院的三种潜在应用场景,包括(1)重症监护病房(ICU),(2)非ICU,以及(3)在医院继续使用家庭CGM。该小组审查了使用障碍以及克服这些障碍的解决方案。他们得出结论,CGM有潜力提高患者护理质量,并能提供有用信息,帮助医疗保健提供者更多地了解血糖管理。然而,医院对CGM的广泛采用受到成本增加和结果数据不足的限制。